A

Abbott India Ltd
NSE:ABBOTINDIA

Watchlist Manager
Abbott India Ltd
NSE:ABBOTINDIA
Watchlist
Price: 28 513.3008 INR -0.16%
Market Cap: 605.9B INR
Have any thoughts about
Abbott India Ltd?
Write Note

Abbott India Ltd
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Abbott India Ltd
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
A
Abbott India Ltd
NSE:ABBOTINDIA
Total Other Income
â‚ą110.9m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Total Other Income
â‚ą9.1B
CAGR 3-Years
25%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Total Other Income
â‚ą7.8B
CAGR 3-Years
42%
CAGR 5-Years
17%
CAGR 10-Years
15%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Total Other Income
â‚ą15.8B
CAGR 3-Years
25%
CAGR 5-Years
12%
CAGR 10-Years
12%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Total Other Income
â‚ą942.9m
CAGR 3-Years
-12%
CAGR 5-Years
5%
CAGR 10-Years
-4%
M
Mankind Pharma Ltd
NSE:MANKIND
Total Other Income
â‚ą768.7m
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Abbott India Ltd
Glance View

Market Cap
605.9B INR
Industry
Pharmaceuticals

Abbott India Ltd., a subsidiary of the global healthcare conglomerate Abbott Laboratories, operates as a key player in India’s pharmaceutical landscape. Nestled in the vibrant, ever-evolving Indian market, Abbott India has carved a niche for itself with a strategic focus on both innovation and localization. Its operations span the development, manufacture, and sale of a wide array of pharmaceutical products. By leveraging Abbott's global expertise and its deep understanding of local market dynamics, the company designs solutions catered to the unique health challenges faced by Indian consumers. Their product portfolio includes a diverse range of proprietary medicines, nutrition products, diagnostics, and branded generics, which address therapeutic areas like cardiology, women's health, gastroenterology, and metabolic disorders. Abbott India’s revenue engine primarily hinges on its extensive distribution networks and its substantial investments in research and development aimed at optimizing treatment paradigms. The company employs a customer-centric approach, working closely with healthcare professionals to ensure the accessibility of its medications across the country. By aligning its operations with the latest trends in healthcare needs and regulatory requirements, Abbott India ensures it remains at the forefront of serving its consumers efficiently. Its commitment to quality and continuous product improvement not only strengthens its market position but also fuels its growth trajectory in the Indian pharmaceutical sector, making it a formidable entity poised for sustained success in a dynamic industry.

ABBOTINDIA Intrinsic Value
16 378.7918 INR
Overvaluation 43%
Intrinsic Value
Price
A

See Also

What is Abbott India Ltd's Total Other Income?
Total Other Income
110.9m INR

Based on the financial report for Mar 31, 2024, Abbott India Ltd's Total Other Income amounts to 110.9m INR.

Back to Top